Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting

被引：0

作者：

Janapala, Rajesh Naidu ^{[1
]}

Patel, Jigar ^{[1
]}

Belfaqeeh, Omar ^{[1
]}

Pourmand, Ali ^{[1
]}

机构：

[1] George Washington Univ, Int Med Program, Sch Med & Hlth Sci, Washington, DC USA

来源：

INTERNATIONAL IMMUNOPHARMACOLOGY | 2021年 / 101卷

关键词：

Mild COVID-19; Hydroxychloroquine; HCQ; Hospitalization; Mortality;

D O I：

10.1016/j.intimp.2021.107878

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We appreciate the efforts of the authors in their study on the clinical outcome of hydroxychloroquine (HCQ) therapy in mild coronavirus disease 2019 (COVID-19) (Mokhtari et al., 2021). We would like to make some comments based on our understanding of the study.

引用

页数：2

共 50 条

[31] Hydroxychloroquine in Hospitalized Patients with Covid-19
Lacout, Alexis
Perronne, Christian
Lounnas, Valere
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (09): : 881 - 882
[32] Outpatient Treatment for COVID-19
Raglow, Zoe
Malani, Preeti N. N.
Petty, Lindsay A. A.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (13): : 1295 - 1295
[33] Outcomes for Patients Following Hospitalization for COVID-19
Prescott, Hallie C.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (15): : 1511 - 1512
[34] Response to COVID-19: The Outpatient Dialysis Setting
Silberzweig, Jeffrey
Wu, Sylvia
Sinclair, Matthew
Watson, Thomas
Welder, Nancy
Concepcion, Danilo
Yee, Jerry
Speed, Felicia
Cukor, Daniel
Schiller, Brigitte
Weiner, Daniel
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2023, 18 (07): : 949 - 952
[35] Recommendations for the Outpatient Drug Treatment of Patients With COVID-19
Kaduszkiewicz, Hanna
Kochen, Michael M.
Kluge, Stefan
Malin, Jakob J.
Weibel, Stephanie
Skoetz, Nicole
DEUTSCHES ARZTEBLATT INTERNATIONAL, 2022, 119 (19): : 342 - 349
[36] Clinical Outcomes of Sotrovimab Treatment in 10 High-Risk Patients with Mild COVID-19: A Case Series
Takeda, Kenichiro
Kasai, Hajime
Sakao, Seiichiro
Saito, Mikihito
Shikano, Kohei
Naito, Akira
Abe, Mitsuhiro
Kawasaki, Takeshi
Yahaba, Misuzu
Taniguchi, Toshibumi
Igari, Hidetoshi
Suzuki, Takuji
AMERICAN JOURNAL OF CASE REPORTS, 2022, 23
[37] Comparative outcomes of lopinavir/ritonavir and hydroxychloroquine for the treatment of COVID-19 with mild-to-moderate severity: A retrospective observational study
Lee, Jeong Eun
Lee, Soon Ok
Heo, Jeonghun
Kim, Dong Wan
Park, Mi Ran
Son, Hyunjin
Kim, Dongkeun
Kim, Kye-Hyung
Lee, Shinwon
Lee, Sun Hee
ANTIVIRAL THERAPY, 2021, 26 (1-2) : 34 - 42
[38] Clinical Efficacy of Hydroxychloroquine or Chloroquine in Patients with COVID-19: An Umbrella Review
Shahsavarinia, Kavous
Ghojazadeh, Morteza
Sanaie, Sarvin
Vahedi, Leila
Ahmadpour, Mahta
Mahmoodpoor, Ata
Soleimanpour, Hassan
PHARMACEUTICAL SCIENCES, 2021, 27 (04) : 481 - 488
[39] Extracorporeal Immunomodulation Treatment and Clinical Outcomes in ICU COVID-19 Patients
Yessayan, Lenar T.
Neyra, Javier A.
Westover, Angela J.
Szamosfalvi, Balazs
Humes, H. David
CRITICAL CARE EXPLORATIONS, 2022, 4 (05) : E0694
[40] Host transcriptomic profiling of COVID-19 patients with mild, moderate, and severe clinical outcomes
Jain, Ruchi
Ramaswamy, Sathishkumar
Harilal, Divinlal
Uddin, Mohammed
Loney, Tom
Nowotny, Norbert
Alsuwaidi, Hanan
Varghese, Rupa
Deesi, Zulfa
Alkhajeh, Abdulmajeed
Khansaheb, Hamda
Alsheikh-Ali, Alawi
Abou Tayoun, Ahmad
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2021, 19 : 153 - 160

← 1 2 3 4 5 →